The most notable companies in this group are JPMorgan Chase & Co (NASDAQ:JPM), Mastercard (NASDAQ:MA), Wells Fargo & Co (NASDAQ:WFC), Philip Morris International (NASDAQ:PM), QUALCOMM (NASDAQ:QCOM), Elevance Health (NASDAQ:ELV), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).
The investment seeks long-term growth of capital.
The fund invests primarily in the equity securities of U.S. companies that the Adviser believes are trading at attractive valuations that have strong or improving business models. The Adviser monitors the fundamental performance of the fund's investments for signs of future financial success. The Adviser relies heavily upon the fundamental analysis and research of its dedicated investment team for the fund in conducting research and making investment decisions.
The average market capitalization across the AB Relative Value Z MF is 221.58B. The market cap for tickers in the group ranges from 86.95B to 632.33B. BRK.B holds the highest valuation in this group at 632.33B. The lowest valued company is REGN at 86.95B.
The average weekly volume growth across all stocks in the AB Relative Value Z MF was -2%. For the same stocks of the MF, the average monthly volume growth was 9% and the average quarterly volume growth was 23%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 48
P/E Growth Rating: 48
Price Growth Rating: 41
SMR Rating: 39
Profit Risk Rating: 38
Seasonality Score: 32 (-100 ... +100)